NCT07446712 Hyperbaric Oxygen Therapy in Complex Regional Pain Syndrome
| NCT ID | NCT07446712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Ostrava |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2028-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-04-01 with a primary completion date of 2028-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to investigate the efficacy of hyperbaric oxygen therapy as an adjunct in the management of severe complex regional pain syndrome.
Eligibility Criteria
Inclusion Criteria: \- Diagnosis of CRPS Type I (without nerve injury) Exclusion Criteria: * HBOT contraindications (pregnancy; use of bleomycin, cisplatin, disulfiram, and doxorubicin; middle ear surgery; untreated pneumothorax or pneumomediastinum; ongoing acute infection; severe decompensation of organ functions or organ failure, severe claustrophobia) * Inability to sign the consent form
Contact & Investigator
Michal Hájek, MD, Ph.D.,
PRINCIPAL INVESTIGATOR
Municipal Hospital Ostrava Fifejdy
Frequently Asked Questions
Who can join the NCT07446712 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07446712 currently recruiting?
Yes, NCT07446712 is actively recruiting participants. Contact the research team at michal.hajek@mnof.cz for enrollment information.
Where is the NCT07446712 trial being conducted?
This trial is being conducted at Ostrava, Czechia, Ostrava, Czechia.
Who is sponsoring the NCT07446712 clinical trial?
NCT07446712 is sponsored by University Hospital Ostrava. The principal investigator is Michal Hájek, MD, Ph.D., at Municipal Hospital Ostrava Fifejdy. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.